GE Vernova Inc vs 22nd Century Group Inc — how do they compare? GE Vernova Inc trades at $1,003.06 (market cap $266.16B), while 22nd Century Group Inc trades at $0.8 (market cap $621.67K). The key difference: GE Vernova Inc is far larger — about 428137.1× 22nd Century Group Inc's market cap, and GE Vernova Inc pays a 0.2% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold GE Vernova Inc for 36 Days and 22nd Century Group Inc for 32 Days on average.
| GEV | XXII | |
|---|---|---|
Market Cap | $266.16B | $621.67K |
Volume | 2,324,165 | 45,625 |
Sector | Industrials | Consumer Staples |
52-Week High | $1.17K | $483.00 |
52-Week Low | $547.96 | $0.80 |
Typical Hold Time | 36 Days | 32 Days |
Enterprise Value | $255.83B | -$3.69M |
Dividend Yield | 0.2% | — |
Signals from Pluang's Aura AI — not financial advice
GE Vernova (GEV) trades at $1,007.77, up 1.07% with strong bullish technical momentum. The stock shows impressive fundamental growth with 2026 revenue projected at $41.4B and net profit margin expanding to 23.03%. Recent catalysts include securing the first US construction permit for its BWRX-300 small modular reactor and a $176B backlog. Analyst consensus remains strongly bullish with 22 buy ratings and a $1,270 price target, representing 26% upside potential from current levels.
The outlook remains positive given the company's positioning in AI-driven power infrastructure demand, though valuation multiples appear elevated with P/E at 28.65 and EV/EBITDA at 85.22. Key risks include execution challenges in the wind segment and competitive pressures in the nuclear energy space. The stock's recent 45% YTD gain suggests much optimism is already priced in, requiring continued strong execution to justify further upside.
22nd Century Group (XXII) trades at $0.89, down 0.94% today, with a bearish technical signal despite oversold RSI readings. The company shows severe financial stress with negative gross margins of -54.6% and net income margin of -76.01%, though valuation metrics appear low with P/S of 0.09 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives and expanded retail distribution for VLN products.
While analyst consensus remains bullish with 75% buy ratings and a $1,240 price target, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock presents high-risk speculation on regulatory adoption of reduced-nicotine standards, requiring careful risk assessment given the company's ongoing losses and cash burn.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.
Read more on GEV →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →